Bibliographic Details
| Title: |
Comparison of QTc interval changes in drug-resistant tuberculosis patients on delamanid-containing regimens versus shorter treatment regimens. |
| Authors: |
Jefman Efendi Marzuki, H.Y.1,2, Nafrialdi, Nafrialdi3, Sawitri, Neni4, Sugiri, Yani Jane5, Gusti Agung Ayu Putu Sri Darmayani, I1,6, Ascobat, Purwantyastuti3 purwanty2703@yahoo.com |
| Source: |
International Journal of Risk & Safety in Medicine. 2024, Vol. 35 Issue 2, p181-190. 10p. |
| Subject Terms: |
*LONG QT syndrome, *RETROSPECTIVE studies, *HOSPITALS, *RELATIVE medical risk, *ELECTROCARDIOGRAPHY, *ANTITUBERCULAR agents, *LONGITUDINAL method, *VENTRICULAR tachycardia, *COMPARATIVE studies, *CONFIDENCE intervals |
| Geographic Terms: |
INDONESIA |
| Abstract: |
BACKGROUND: Delamanid (DLM) is a relatively new drug for drug-resistant tuberculosis (DR-TB) that has been used in Indonesia since 2019 despite its limited safety data. DLM is known to inhibit hERG potassium channel with the potential to cause QT prolongation which eventually leads to Torsades de pointes (TdP). OBJECTIVE: This study aims to analyse the changes of QTc interval in DR-TB patients on DLM regimen compared to shorter treatment regimens (STR). METHODS: A retrospective cohort was implemented on secondary data obtained from two participating hospitals. The QTc interval and the changes in QTc interval from baseline (ΔQTc) were assessed every 4 weeks for 24 weeks. RESULTS: The maximum increased of QTc interval and ΔQTc interval were smaller in the DLM group with mean difference of 18,6 (95%CI 0.3 to 37.5) and 31.6 milliseconds (95%CI 14.1 to 49.1) respectively. The proportion of QTc interval prolongation in DLM group were smaller than STR group (RR=0.62; 95%CI 0.42 to 0.93). CONCLUSION: This study has shown that DLM regimens are less likely to increase QTc interval compared to STR. However, close monitoring of the risk of QT interval prolongation needs to be carried out upon the use of QT interval prolonging antituberculoid drugs. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Risk & Safety in Medicine is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
